Log In
BCIQ
Print this Print this
 

Symproic, naldemedine (S-297995)

  Manage Alerts
Collapse Summary General Information
Company Shionogi & Co. Ltd.
DescriptionOral peripheral mu opioid receptor (MOR; OPRM1) antagonist
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of ActionMu opioid receptor antagonist
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/19/2016

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today